H.R. 4627 modifies how the U.S. government directs foreign aid to combat HIV/AIDS by expanding what counts as core humanitarian assistance under existing law. The bill specifically adds HIV pre-exposure prophylaxis (PrEP) medications to the list of preventive treatments the government can fund internationally, and clarifies that prevention efforts—including pre- and post-exposure measures—are considered life-saving humanitarian assistance. The legislation also ensures that prevention programs target at-risk populations using scientific analysis recommended by the World Health Organization. The bill affects U.S. foreign aid priorities and international HIV/AIDS prevention efforts but does not specify new funding amounts or implementation timelines. It was introduced in July 2025 by a bipartisan group of House members and referred to the Committee on Foreign Affairs.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.